menu
    • menu

    Company profile for Enlivex Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission is to establish new equilibriums – both in patients’ immune responses and in the field of immunotherapy. As a clinical-stage company focused on specialized cell immunotherapy, we intend to develop and commercialize an allogeneic drug pipeline for rebalancing all manner of immune hyper-responses. Our pioneering Allocetra™ cell-based therapy breaks with old paradigms, offering to effectively treat numerou...
    Our mission is to establish new equilibriums – both in patients’ immune responses and in the field of immunotherapy. As a clinical-stage company focused on specialized cell immunotherapy, we intend to develop and commercialize an allogeneic drug pipeline for rebalancing all manner of immune hyper-responses. Our pioneering Allocetra™ cell-based therapy breaks with old paradigms, offering to effectively treat numerous acute conditions through a radically different clinical approach. By using the body’s native mechanisms to restore – rather than suppress –

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Enlivex TherapeuticsIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    14 Einstein St. Nes-Ziona 7403618
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://enlivex.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/enlivex-therapeutics-nasdaq-enlv
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enlivex Finalizes $212M Private Placement
    Enlivex Finalizes $212M Private Placement

    26 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/26/3195104/0/en/Enlivex-Announces-Closing-of-Previously-Announced-212-000-000-Private-Placement.html

    GLOBENEWSWIRE
    26 Nov 2025
    Share Share
    Enlivex Reports Positive 6-Month Data For Knee Osteoarthritis
    Enlivex Reports Positive 6-Month Data For Knee Osteoarthritis

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193332/0/en/Enlivex-Announces-Positive-6-Month-Topline-Data-Demonstrating-Durable-and-Persistent-Pain-Reduction-and-Improved-Function-in-Primary-Age-Related-Patients-with-Moderate-to-Severe-Kn.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Enlivex to Present Ph IIa Allocetra Data in Knee Osteoarthritis
    Enlivex to Present Ph IIa Allocetra Data in Knee Osteoarthritis

    28 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/28/3175403/0/en/Enlivex-Therapeutics-to-Present-Phase-IIa-3-month-Data-of-Allocetra-in-Patients-with-Moderate-to-Severe-Knee-Osteoarthritis-at-the-ACR-Convergence-2025.html

    GLOBENEWSWIRE
    28 Oct 2025
    Share Share
    Boral Capital Hosts Kol Webinar On Enlivex's Knee Osteoarthritis
    Boral Capital Hosts Kol Webinar On Enlivex's Knee Osteoarthritis

    29 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/29/3157701/0/en/D-Boral-Capital-to-Host-KOL-Webinar-With-World-Leading-Experts-Featuring-Insights-Breakthroughs-from-Enlivex-s-Knee-Osteoarthritis-Program.html

    GLOBENEWSWIRE
    29 Sep 2025
    Share Share
    Enlivex CEO Shares Roadmap After Positive Ph 2a Allocetra Data
    Enlivex CEO Shares Roadmap After Positive Ph 2a Allocetra Data

    11 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/11/3148511/0/en/Enlivex-CEO-Issues-Letter-to-Shareholders-Outlining-Strategic-Roadmap-Following-Positive-Phase-IIa-Allocetra-Results.html

    GLOBENEWSWIRE
    11 Sep 2025
    Share Share
    Enlivex Wins Patent for Allocetra Use in Osteoarthritis Therapy
    Enlivex Wins Patent for Allocetra Use in Osteoarthritis Therapy

    09 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/09/3146853/0/en/Enlivex-Announces-Issuance-of-New-Patent-Application-Covering-the-Use-of-Allocetra-in-Patients-with-Osteoarthritis.html

    GLOBENEWSWIRE
    09 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search